Drug Shortage Report for AURO-METRONIDAZOLE
Report ID | 217655 |
Drug Identification Number | 02470284 |
Brand name | AURO-METRONIDAZOLE |
Common or Proper name | AURO-METRONIDAZOLE |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | METRONIDAZOLE |
Strength(s) | 500MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100's |
ATC code | P01AB |
ATC description | AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DIS. |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-01-29 |
Estimated end date | 2024-04-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-03-27 | French | Compare |
v4 | 2024-03-27 | English | Compare |
v3 | 2024-01-30 | English | Compare |
v2 | 2024-01-29 | French | Compare |
v1 | 2024-01-29 | English | Compare |
Showing 1 to 5 of 5